HRTS241220C42000
- 0.00
- 0.000.00%
Tema GLP-1, Obesity & Cardiometabolic ETF Newsroom
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Trading Halt: Halted at 4:08:53 P.m. ET - Trading Halt: Halt News Pending
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Market Climbs, Bitcoin Close to $100k | Live Stock
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Expanding while keeping an eye on the movements of the USA market.
The Nikkei index rebounded for the first time in three days, closing at 38,283.85 yen, up 257.68 yen (with an estimated volume of 1.6 billion 80 million shares). Following the rebound of nvidia in the previous day's usa market, more stocks rose in the Tokyo market, particularly in the semiconductors sector. Additionally, buying aimed at a self-rebound in response to the previous day's declines contributed to the rise, and the Nikkei index increased to 38,420.63 yen towards the end of the morning session. However, there are movements to adjust positions ahead of the weekend, and investors want to assess the situation in Russia and Ukraine.
Maruha Nichiro, Chugai Pharmaceutical, etc. (additional) Rating
Upgrades - bullish Code Stock Name Securities Company Previous Change After ------------------------------------------------------- <1802>Obayashi Corporation SMBC Nikko "2" "1" <1808>Haseko Corporation SMBC Nikko "2" "1" Downgrades - bearish Code Stock Name Securities Company Previous Change After ------------------------------------------------------- <3382>
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $103
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Eli Lilly in Pact With Chinese Biotech for Novel Weight Loss Therapy